TrialJournal of Korean medical science2022

Outcomes of On-Label Reduced-Dose Edoxaban in Patients With Atrial Fibrillation: The LEDIOS Registry.

Ju Youn Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.